Novartis says its CIBA Vision division raised its sales by 33 percent in local currencies and by percent in Swiss francs to 1.8 billion SF (e1.2bn-$1.1bn) in 2001, with the newly acquired Wesley Jessen operation accounting for 28 percentage points of the growth. The diversified Swiss pharmaceutical group is confident ...

Buying a membership today will give you:
To continue reading this article register now.